METTL16 and pancreatic neoplasm: From the GEO databases GSE15471 and GSE16515, it was found that the METTL16 mRNA levels are downregulated in pancreatic cancer (GSE15471, p = 0.0202 and GSE16515, p = 0.0007) (Figure S1A).